Beaston-Blaakman, A <br/><br/>
Cost-effectiveness of clinical interventions for AIDS wasting.  [electronic resource] 

 -  AIDS care  Sep 2007 
 - 996-1001 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0954-0121 
<br/><br/><label>Standard No.: </label>10.1080/09540120701335238  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anabolic Agents--economics<br/>Antiretroviral Therapy, Highly Active<br/>Boston--epidemiology<br/>Cost-Benefit Analysis<br/>Female<br/>HIV Wasting Syndrome--economics<br/>Humans<br/>Male<br/>Nutritional Physiological Phenomena<br/>Oxandrolone--economics<br/>Randomized Controlled Trials as Topic--economics<br/>Treatment Outcome